Pfizer's oral HER2 inhibitor Tukysa looks poised to find a new role as first-line maintenance therapy for HER2-positive metastatic breast cancer, based on now-revealed data from the HER2CLIMB-05 study ...
Georgia-based HydrauliCircuit Technology (HCT) offers hydraulics and coupler kits and guarding options for excavators used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results